In this survey we will be reviewing the stocks that make up the North American Marijuana Index. In Part 1, we’ll look at Canopy Growth Corp. (OTCPK:TWMJF), GW pharmaceuticals (NASDAQ:GWPH), Axim Biotechnologies Inc. (OTCQB:AXIM), and United Cannabis Corp. (OTCQB:CNAB).
Aphria Inc. is the newest weed company to graduate to the TSX. The stock has been faring better than its peers, Canopy Growth Corp. and Aurora Cannabis Inc. over the past few months.
Beyond the legal issues, the problem for investors is that the industry is filled with small publicly traded companies that are risky bets at best, and outright fraudulent at worst.
MyDx (OTCQB:MYDX) Stock Chart Technical Analysis for March 24, 2017.
Insys Therapeutics’ stock rose on good news — but not tremendously so.
Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.
Major cannabis stock indices have been falling for three consecutive weeks, ever since White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized.
Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
Canopy Growth Corporation (TSX:WEED) is being added to the influential S&P/TSX Composite Index in another milestone for Canada’s fledgling marijuana industry.
On March 9, 2017, the Colorado Department of Regulatory Agencies announced that Colorado Securities Commissioner Gerald Rome has ordered John W. Long, Jr., of Nederland, as well as his marijuana businesses, Green Farms Consulting and Green Farms Holdings, to cease and desist offering and selling unregistered securities.
There’s been something in the air on the ASX recently and it’s inducing some strange behaviour in traders betting on higher and higher share prices in some emerging companies.
The California Cannabis Business Expo wound down on March 8, closing with two panels at the Marijuana Investor Summit: one featuring the CEOs of three U.S. based firms active in the cannabis space; the other featuring four business and financial executives from Canada, who could speak to the state of the same industry in a very different legal and cultural context.
The cannabis industry’s excitement is building as the California takes steps towards establishing its legal recreational market. This week Los Angeles voters approved Measure M to create regulations for adult-use marijuana, thus setting up the city to steal the title of marijuana capital from Denver.
Publicly-traded marijuana companies had a rough week but got a bounce Thursday following news of raids at the Cannabis Culture dispensary chain owned by Marc and Jodie Emery.
The investing community demands regular performance updates in the form of financial reports. While the need to impress investors is creating pressure for the infant marijuana industry, are the companies fairly reporting performance?
An industry previously only regulated by law enforcement leaves tremendous uncertainty for those looking to get into the industry from an investment perspective. Organizations like MJIC are stepping up to provide regulatory support and protection for marijuana operators.
While it is still difficult to invest directly in legal pot through public equities, venture capital firms and private equity funds have raised hundreds of millions of investment dollars.
CannaPitch, a cannabis industry live pitch session featuring five industry experts as pitch appraisers on the one hand and a unique set of entrepreneurs on the other, proved the highlight of the first day of the California Cannabis Business Expo, in San Diego, on March 5, 2017.
Reports continue to emerge of young teens overdosing and sometimes dying due to the use of drugs containing fentanyl, a potent synthetic opioid. Smoking pot is different than popping pills, but the risk for the government is that the lines might get blurred quite quickly in the eyes of parents who are trying to protect their kids from the current opioid threat.
Proceed with caution, said a number of speakers taking part in the California Cannabis Business Expo, which runs through Wednesday at the San Diego Sheraton Hotel and Marina.
A newly released survey from the independent Quinnipiac University really demonstrates just how strongly the American public wants to see marijuana legalized, and how certain they are that state’s rights should prevail.
Insys Therapeutics announced a compassionate-use program for its cannabis-based epilepsy drug, igniting optimism that the company is continuing to develop marijuana medicine.
Bets on marijuana companies helped an Australian manager soar 145 percent last year to become the world’s best-performing hedge fund.
Investors are becoming more and more impressed with the job CEO Terry Booth and his team are doing at Aurora Cannabis Inc. After posting strong Q2 results and closing a C$75 million financing, there’s a lot to like with company.
A federal crackdown on marijuana isn’t bad news for all marijuana stocks.
While President Donald Trump vowed on his campaign trail to let states decide the fate of marijuana legalization, recent comments by the Trump Administration seem to negate his campaign promise and have created a ripple effect in the public cannabis markets.
In the last trading session, the stock price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 8% to close the day at $0.112. The decline came at a share volume of 24.74 million compared to average share volume of 17.32 million.
Advocates, investors and entrepreneurs believe that the profile of marijuana users will change now that cannabis is legal. They all have one thing in common — wanting to make money from the new cannabis consumer.
Shares of Canadian and U.S. marijuana producers fell Friday after the Trump administration suggested a crackdown on recreational marijuana may be in the works.
Heightened public awareness leading up to the U.S. elections in November drew in massive increases in trading volume, pushing the U.S. Marijuana Index and Canadian Marijuana Index to double in price in less than a two-month period in September and October.
Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.
It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.
Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.
Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.
Since seeing all the buzz and craze these companies are causing in the marketplace, we’ve been hot on the trail of companies tied to the cannabis sector. The budding marijuana industry has spawned several high flying stocks lately, like Mentor Capital Inc.
Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.
The cannabis industry is expected to reach $50 billion in size by 2026, according to Cowen & Co., making it one of the fastest growing industries in the world. Investors have taken a growing interest in the industry as legalization has spread across North America. Here are three subsets of the cannabis industry that investors may want to consider for the best risk-adjusted returns.
Marijuana stocks are riding high as the stock index is up for the eighth consecutive week.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
“We are continuing to see Canadian companies invest in or acquire assets in U.S. cannabis markets […] looking to take advantage of increased demand abroad,” a Viridian Capital analyst says.
Gaelan Bloomfield and Ram Venkay, partners in a new investment fund that will be managed from Australia and will focus on Calif.-based cannabis investment opportunities, are notably wary about the prospects at home, Down Under.
Roto-Gro International, a Canadian cannabis-tech company has been admitted to the ASX, and has become the latest player to join the list of cannabis based companies on the ASX.
Canopy Growth Corporation’s generating eye-popping returns for investors. However, there are risks ahead that could rein in some investor optimism.
Marijuana prices are falling. Could marijuana stock prices drop soon, too?
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
As of Wednesday, traders on the Toronto Stock Exchange can buy and sell “WEED.”
While there are a number of big issues and industries that could be impacted by the Gorsuch nomination (should he be confirmed), the marijuana industry and marijuana stocks have to be wondering how this nomination could impact them.
Startups are finding new ways to tailor technologies specifically to cannabis businesses.
A federal court in Boston last week entered judgments against a publicly traded company purportedly serving medical marijuana businesses over allegations that it defrauded investors by lying about the company’s true owner.